Correlation Between Merck and Geron
Can any of the company-specific risk be diversified away by investing in both Merck and Geron at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Merck and Geron into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Merck Company and Geron, you can compare the effects of market volatilities on Merck and Geron and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Merck with a short position of Geron. Check out your portfolio center. Please also check ongoing floating volatility patterns of Merck and Geron.
Diversification Opportunities for Merck and Geron
Very poor diversification
The 3 months correlation between Merck and Geron is 0.82. Overlapping area represents the amount of risk that can be diversified away by holding Merck Company and Geron in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Geron and Merck is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Merck Company are associated (or correlated) with Geron. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Geron has no effect on the direction of Merck i.e., Merck and Geron go up and down completely randomly.
Pair Corralation between Merck and Geron
Considering the 90-day investment horizon Merck Company is expected to generate 0.57 times more return on investment than Geron. However, Merck Company is 1.76 times less risky than Geron. It trades about -0.01 of its potential returns per unit of risk. Geron is currently generating about -0.03 per unit of risk. If you would invest 10,373 in Merck Company on August 30, 2024 and sell it today you would lose (61.00) from holding Merck Company or give up 0.59% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Strong |
| Accuracy | 100.0% |
| Values | Daily Returns |
Merck Company vs. Geron
Performance |
| Timeline |
| Merck Company |
| Geron |
Merck and Geron Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Merck and Geron
The main advantage of trading using opposite Merck and Geron positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Merck position performs unexpectedly, Geron can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Geron will offset losses from the drop in Geron's long position.| Merck vs. Emergent Biosolutions | Merck vs. Bausch Health Companies | Merck vs. Neurocrine Biosciences | Merck vs. Teva Pharma Industries |
| Geron vs. Viking Therapeutics | Geron vs. TG Therapeutics | Geron vs. X4 Pharmaceuticals | Geron vs. PDS Biotechnology Corp |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.
Other Complementary Tools
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Fundamental Analysis View fundamental data based on most recent published financial statements |